Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models.
about
Erythropoiesis stimulating agents and reno-protection: a meta-analysisTreatment of renal anemia: Erythropoiesis stimulating agents and beyond.Mechanisms and consequences of carbamoylation.Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?Activation of the β-common receptor by erythropoietin impairs acetylcholine-mediated vasodilation in mouse mesenteric arterioles.Carbamylated Erythropoietin Decreased Proliferation and Neurogenesis in the Subventricular Zone, but Not the Dentate Gyrus, After Irradiation to the Developing Rat Brain
P2860
Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Carbamylated Erythropoietin Ou ...... I-on-CKD and Other AKI Models.
@en
Carbamylated Erythropoietin Ou ...... I-on-CKD and Other AKI Models.
@nl
type
label
Carbamylated Erythropoietin Ou ...... I-on-CKD and Other AKI Models.
@en
Carbamylated Erythropoietin Ou ...... I-on-CKD and Other AKI Models.
@nl
prefLabel
Carbamylated Erythropoietin Ou ...... I-on-CKD and Other AKI Models.
@en
Carbamylated Erythropoietin Ou ...... I-on-CKD and Other AKI Models.
@nl
P2093
P2860
P356
P1476
Carbamylated Erythropoietin Ou ...... I-on-CKD and Other AKI Models.
@en
P2093
Christof Westenfelder
Florian E Tögel
Jon D Ahlstrom
Ping Zhang
P2860
P304
P356
10.1681/ASN.2015091059
P577
2016-03-16T00:00:00Z